Overcoming the challenges of the pharmaceutical industry

May 23, 2019

Ahead of the FT Pharmaceutical and Biotech Conference on 11-12 November 2019, we gathered some of the leading figures in the pharmaceutical industry at the Financial Times' headquarters for a morning of discussions on the key issues the industry is facing.

Spotlight

Ajanta Pharma Ltd

Ajanta Pharma Limited (APL) is a pharmaceutical company headquartered in Mumbai, India. It has strong presence in Branded Generic business in India & Emerging markets; and Generic business in USA.In India, company operates in selected therapeutic areas of Cardiology, Dermatology, Ophthalmology and Pain management. Its brands in each of sub-therapeutic areas or molecules hold leadership positions.In Emerging Markets, company has presences in Africa, Asia, Middle East, and CIS on broader therapeutic segments such as anti-malarial, gastro, antibiotics, cardiology, dermatology, pain management, etc.

OTHER VIDEOS

Computational Drug Discovery and Design

video | October 2, 2022

Computational Drug Designing has become the go-to requirement for the researchers, scientists and the pharmaceuticals who fight against the fatal disease....

Watch Now

How Important is Data Integrity to Your Lab Work?

video | September 28, 2022

As a compliance leader performing over 30,000 Operational Qualifications every year, Agilent continues to invest in solutions that address the needs of the market....

Watch Now

Pharmacy Management Software

video | October 1, 2022

Unipro Software Pte Ltd is a home grown software company which provides software services and system integration services to many organisations....

Watch Now

Huawei Cloud AI Model Accelerates New Drug Discovery

video | September 22, 2022

pre-trained AI models have greatly sped up pharma R&D, with multi-year tasks, such as identify lead compounds,...

Watch Now

Spotlight

Ajanta Pharma Ltd

Ajanta Pharma Limited (APL) is a pharmaceutical company headquartered in Mumbai, India. It has strong presence in Branded Generic business in India & Emerging markets; and Generic business in USA.In India, company operates in selected therapeutic areas of Cardiology, Dermatology, Ophthalmology and Pain management. Its brands in each of sub-therapeutic areas or molecules hold leadership positions.In Emerging Markets, company has presences in Africa, Asia, Middle East, and CIS on broader therapeutic segments such as anti-malarial, gastro, antibiotics, cardiology, dermatology, pain management, etc.

Events